The 38th Annual General Meeting of Navana Pharmaceuticals PLC, a listed company, has been held. The shareholders have approved a cash dividend of 14 percent for the financial year ended June 30, 2024.
The meeting, held in hybrid format on Tuesday (December 31).
The meeting was presided over by the Chairman of the company, Prof. Dr. Sardar A. Naeem. The meeting was attended by the Acting Managing Director of the company, Dr. Saeed Ahmed and other esteemed directors, auditors and management officers of the company, among others.
The shareholders appreciated the company for declaring a cash dividend of 14 percent for the year ended 2023-2024 only for ordinary shareholders and for consistently paying good dividends.
At the same time, the shareholders appreciated the management for maintaining sustainable growth in sales revenue, net profit and EPS.
